1,712
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Clinical importance of serum secreted clusterin in predicting invasive breast cancer and treatment responses

, , , & ORCID Icon
Pages 278-285 | Received 23 Oct 2020, Accepted 21 Dec 2020, Published online: 28 Jan 2021

Figures & data

Table 1. Clinicopathologic characteristics of patients with invasive breast cancer

Table 2. Relationship between sCLU levels and clinicopathological factors in 1998 IBC patients

Figure 1. Serum sCLU levels in IBC and controls. Serum sCLU yielded an AUC value of 0.87 in distinguishing IBC from controls

Figure 1. Serum sCLU levels in IBC and controls. Serum sCLU yielded an AUC value of 0.87 in distinguishing IBC from controls

Figure 2. Kaplan-Meier survival curves. Percent survival rate was stratified by serum sCLU level. A, overall survival of patients;B, progression-free survival

Figure 2. Kaplan-Meier survival curves. Percent survival rate was stratified by serum sCLU level. A, overall survival of patients;B, progression-free survival

Figure 3. ELISA detection of serum sCLU levels. A, Surgical patients; B, Chemotherapy patients

Figure 3. ELISA detection of serum sCLU levels. A, Surgical patients; B, Chemotherapy patients
Supplemental material

Supplemental Material

Download ()